期刊文献+

补血益母颗粒防治药物流产后阴道出血89例 被引量:1

Buxueyimu Granules for Treating and Prevening Hemorrhage after Medicine Abortion in 89 Cases
下载PDF
导出
摘要 目的观察补血益母颗粒防治药物流产后阴道出血的疗效与安全性。方法选择无药物流产禁忌证的早孕妇女178例,随机单盲对照均分为观察组和对照组。药物流产采用相同服药剂量与方法,见孕囊排出后,观察组服用补血益母颗粒1包,对照组服用益母草冲剂1包,两组均2次/d,连续7d,同时加服奥硝唑0.5g,1次/d,连续6d。结果观察组药物流产后阴道出血时间、出血量、完全流产率、2周后尿人绒毛膜促性腺激素(HCG)转阴率等指标均优于对照组(P>0.01)。结论药物流产后服用补血益母颗粒,可缩短阴道出血时间、减少出血量,提高完全流产率及2周后尿HCG转阴率。 Objective To investigate the curative effect and safety of Buxueyimu Granules on treating and preventing raginal hemorrhage after medicine abortion. Methods 178 cases of medicine abortion were divided into 2 groups randomly. 89 cases in the treatment group were given Buxueyimu Granules, 1 bag, b. i. d.,for 7 d. 89 cases in the control group took Yimucao Instant Powder, 1 bag, b. i. d.,for 7 d. At the same time. All patients got the same medicine abortion, and took onidazole 0. 5 g, q. d., for 6 d after abortion. Results The treatment group had shorter vaginal hemorrhage time, less quantity of hemorrhage, higher rate of complete aborting compared with the control group. Conclusion Taking Buxueyimu Granules after medicine abortion can shorten the time of hemorrhage, decrease quantity of hemorrhage, increase the complete abortion rate and negative turning rate of urine HCG after 2 week.
出处 《中国药业》 CAS 2008年第11期66-67,共2页 China Pharmaceuticals
关键词 补血益母颗粒 药物流产 阴道出血 Buxueyimu Granules medicine abortion vaginal hemorrhage
  • 相关文献

参考文献3

二级参考文献21

  • 1许梅芬,金毓翠,岑幻仙,李红,程利南,张于屏.药物流产后子宫刮出物的组织学观察[J].中华妇产科杂志,1994,29(12):739-741. 被引量:251
  • 2刘伯宁,孙剑英,陶雯琪,蔡敏芳,杨美娟.米非司酮终止早孕流产物的病理观察[J].中华妇产科杂志,1995,30(1):7-9. 被引量:104
  • 3Chan Y F,Contraception,1993年,47卷,85页 被引量:1
  • 4Cheng L N,Hum Reprod,1993年,8卷,705页 被引量:1
  • 5贺昌海,中国计划生育学杂志,1992年,2卷,19页 被引量:1
  • 6肖碧莲,中华妇产科杂志,1980年,15卷,3期,159页 被引量:1
  • 7WHO.Task force on post ovulatory methods for fertility regulation: termination of early human pregnancy with RU 486 ( mifeprestone ) and the prostaglandin analogue Sulprostone: a multicenter randomized comparison between two treatment regimens. Human Reproduction . 1989 被引量:2
  • 8WHO Task Force on post-ovulatory methods for Fertility Regulation.Pregnancy termination with minfepristone and gemeprpst:a multi-center comparison between repeated doses and a single of mifepristone. Fertility and Sterility . 1991 被引量:1
  • 9He Chang-hai.et al.Clinical pharmacodynamics of mifepristone (RU486) in the Chinese pregnant women. Second International Conference on Reproductive Endocrinology . 1992 被引量:1
  • 10WHO.Differences in Coagulation and Haemostatic Parameters in Normal Women of Childbearing Age from Different Ethnic Groups and Geographical Locations. Thrombosis and Haemostasis . 1986 被引量:1

共引文献163

同被引文献65

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部